Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-19 | New | $3,384,616 | $3,384,616 | Other | 06b | SEC link |
| 2024-09-04 | New | $0 | $0 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Yaron Eldad | Executive |
| Dan Falk | Director |
| Sarit Firon | Director |
| Ofer Haviv | Director, Executive |
| Mark Kapel | Executive |
| Sassi Masliah | Executive |
| Nir Nimrodi | Director |
| Adrian Percy | Director |
| Leon Yehuda Recanati | Director |
| Eyal Ronen | Executive |
| Oded Shoseyov | Director |
| Gabi Tarcic | Executive |
| Ilia Zhidkov | Executive |